HIGH

Glenmark Pharmaceuticals Recalls Carvedilol Tablets Over Nitrosamine Risk

Glenmark Pharmaceuticals recalled 4,800 bottles of Carvedilol Tablets on August 7, 2025. The recall stems from CGMP deviations leading to high levels of nitrosamine impurities. Consumers should stop using the product immediately and consult healthcare providers for guidance.

Quick Facts at a Glance

Recall Date
August 7, 2025
Hazard Level
HIGH
Brands
Glenmark Pharmaceuticals, CARVEDILOL
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled product is Carvedilol Tablets, USP, 25 mg, in 500-count bottles. The National Drug Code (NDC) is 68462-165-05. These tablets were distributed nationwide in the USA.

The Hazard

The recall involves the presence of N-Nitroso Carvedilol I impurity above acceptable intake levels. This contamination poses a significant health risk to consumers.

Reported Incidents

No specific incidents or injuries have been reported in connection with this recall. The risk level is classified as high due to the potential health implications.

What to Do

Consumers should stop using Carvedilol Tablets immediately. Contact Glenmark Pharmaceuticals Inc., USA, or consult your healthcare provider for further guidance.

Contact Information

For more information, call Glenmark Pharmaceuticals Inc. at 1-800-XXX-XXXX or visit their website. Additional details are available at the FDA's recall page.

Key Facts

  • Recall date: August 7, 2025
  • Report date: August 20, 2025
  • Quantity recalled: 4,800 bottles
  • Impurity: N-Nitroso Carvedilol I
  • Manufactured in Goa, India

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot#:19243104
Expires: 7/31/2026.
UPC Codes
68462-162
68462-163
68462-164
+11 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more